Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
5.94 Down 0.41(6.46%) Feb 5, 4:00PM EST
|After Hours : 5.74 Down 0.20 (3.37%) Feb 5, 5:40PM EST
Prev Close:6.35
Open:6.47
Bid:5.75 x 1000
Ask:6.67 x 400
1y Target Est:29.00
Beta:2.04275
Earnings Date:Mar 1 - Mar 2 (Est.)
Day's Range:5.83 - 6.81
52wk Range:5.23 - 21.22
Volume:691,896
Avg Vol (3m):449,889
Market Cap:310.92M
P/E (ttm):N/A
EPS (ttm):-1.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.19
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback